Ipsen, S.A. 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Oct 10, 2017
Insider Transaction Report
Form 4
Ipsen, S.A.
10% Owner
Transactions
- Conversion
Common Stock
2017-10-10+45,831→ 645,161 total(indirect: The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA) - Purchase
Common Stock
2017-10-10$17.00/sh+20,000$340,000→ 833,099 total(indirect: The owner of record of the securities is Ipsen Pharma, S.A.S., which is controlled by Ipsen SA) - Conversion
Series A-1 Junior Preferred Stock
2017-10-10−45,831→ 0 total(indirect: The owner of record of the securities is Sutrepa SAS.Sutrepa SAS is controlled by Ipsen SA)→ Common Stock (45,831 underlying) - Conversion
Series A Convertible Preferred Stock
2017-10-10−167,938→ 0 total(indirect: The owner of record of the securities is Sutrepa SAS.Sutrepa SAS is controlled by Ipsen SA)→ Common Stock (167,938 underlying) - Conversion
Common Stock
2017-10-10+167,938→ 813,099 total(indirect: The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA)
Footnotes (2)
- [F1]In connection with the closing of the Issuer's initial public offering, each share of the Issuer's series A convertible preferred stock (the "Series A Preferred") and series A-1 junior preferred stock (the "Series A-1 Preferred") converted into the Issuer's common stock on a 9.17-for-one basis without payment or consideration. The Series A Preferred and the Series A-1 Preferred had no expiration date.
- [F2]Reflects the number of shares of Series A Preferred and Series A-1 Preferred, as applicable, held by the Reporting Person on an as-converted to common stock basis.